Imugene Limited (ASX:IMU)

Imugene Revenue

Imugene had revenue of 1.26M AUD in the half year ending December 31, 2024, a decrease of -73.86%. This brings the company's revenue in the last twelve months to -1.84M, down -112.24% year-over-year. In the fiscal year ending June 30, 2024, Imugene had annual revenue of 4.97M, down -57.80%.

• Revenue (ttm): -1.84M
• Revenue Growth: -112.24%
• P/S Ratio: -44.17
• Revenue / Employee: -367.92K
• Employees: 5
• Market Cap: 81.26M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	4.97M	-6.81M	-57.80%
Jun 30, 2023	11.78M	-1.19M	-9.19%
Jun 30, 2022	12.97M	5.74M	79.35%
Jun 30, 2021	7.23M	3.10M	74.94%
Jun 30, 2020	4.13M	6.56K	0.16%